Global NGS Sample Preparation Market Size study & Forecast, by Product (Reagents & Consumables, Workstations), by Workflow (Library Prep, Target Enrichment), by Sample Type (DNA), by Application (Diagnostics, Drug Discovery), by Method (Microfluidic, Auto

The Global NGS (Next-Generation Sequencing) Sample Preparation Market, valued at approximately USD 2.44 billion in 2024, is projected to expand at a remarkable CAGR of around 13.40% from 2025 to 2035. The NGS sample preparation process is a critical step in enabling high-throughput genomic analysis, ensuring that biological samples are transformed into high-quality sequencing-ready libraries. Over the past decade, the integration of NGS into clinical diagnostics, precision medicine, and advanced research has created a surging demand for faster, more reliable, and automation-friendly preparation workflows. The growing prevalence of genetic disorders, the rising adoption of companion diagnostics, and the expanding applications of genomics in drug discovery have collectively reinforced the significance of robust sample preparation solutions. Furthermore, the global shift toward personalized healthcare is encouraging researchers and clinical laboratories to invest heavily in technologies that minimize hands-on time, reduce errors, and improve reproducibility.

The acceleration in genomic research activities and the declining cost of sequencing have intensified the requirement for efficient, scalable, and high-yield sample preparation systems. Innovations in microfluidic technologies, the launch of integrated workstations, and the development of reagent kits tailored for specific applications are driving competitive differentiation in the market. For instance, library preparation and target enrichment workflows are increasingly being optimized for minimal sample input while maximizing sequencing accuracy and throughput. According to industry reports, the demand for NGS-based diagnostic testing is forecast to witness exponential growth, fueled by expanding cancer genomics programs, infectious disease surveillance, and pharmacogenomics research. However, the market continues to face challenges such as high instrument and reagent costs, complex regulatory requirements for clinical-grade sequencing, and the need for specialized technical expertise in workflow optimization.

Geographically, North America dominates the NGS Sample Preparation Market, underpinned by its robust healthcare infrastructure, significant investment in genomics research, and early adoption of precision medicine initiatives. The U.S., in particular, benefits from strong funding support from government bodies such as the NIH, fostering the rapid deployment of sequencing technologies in clinical and research settings. Europe holds a substantial share as well, driven by advancements in molecular diagnostics, collaborative genomic initiatives across EU member states, and an established base of biotechnology companies. Meanwhile, the Asia Pacific region is poised for the fastest growth during the forecast period, supported by large-scale genomic projects in China, India, and Japan, along with rising investments in biotechnology infrastructure. Countries in Latin America and the Middle East & Africa are gradually expanding their NGS capabilities, primarily through public-private partnerships and collaborations with global sequencing solution providers.

Major market player included in this report are:
• Illumina, Inc.
• Thermo Fisher Scientific Inc.
• Agilent Technologies, Inc.
• QIAGEN N.V.
• PerkinElmer, Inc.
• F. Hoffmann-La Roche Ltd.
• Bio-Rad Laboratories, Inc.
• Takara Bio Inc.
• Oxford Nanopore Technologies Ltd.
• BGI Genomics Co., Ltd.
• Pacific Biosciences of California, Inc.
• Beckman Coulter, Inc. (Danaher Corporation)
• New England Biolabs, Inc.
• Hamilton Company
• Zymo Research Corporation

Global NGS Sample Preparation Market Report Scope:
• Historical Data – 2023, 2024
• Base Year for Estimation – 2024
• Forecast period - 2025-2035
• Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players.

The detailed segments and sub-segments of the market are explained below:

By Product:
• Reagents & Consumables
• Workstations

By Workflow:
• Library Prep
• Target Enrichment

By Sample Type:
• DNA

By Application:
• Diagnostics
• Drug Discovery

By Method:
• Microfluidic
• Automated

By End User:
• (End User segmentation details to be included if specified)

By Region:

North America
• U.S.
• Canada

Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE

Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC

Latin America
• Brazil
• Mexico

Middle East & Africa
• UAE
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Key Takeaways:
• Market Estimates & Forecast for 10 years from 2025 to 2035.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions. Show more